By proceeding, you agree to our Terms of Use and Privacy Policy.
Dr. Alun Bermingham serves as the Senior Vice President and Head of Platform at Totus Medicines, where he spearheads the execution and ongoing development of the OmniDEL platform. This innovative technology is at the forefront of enabling the discovery of novel therapeutics for challenging targets. With a Ph.D. in Biochemistry and over two decades of experience in drug discovery, Dr. Bermingham brings a profound understanding of the molecular mechanisms and interactions that underlie disease processes and drug action.Throughout his illustrious career, Dr. Bermingham has excelled in building and leading high-performing teams and organizations, delivering impactful biological insights, and innovating solutions for multiple research programs. His extensive expertise spans chemical biology, assay development, enzyme kinetics, biophysical and mechanistic evaluation, high-throughput screening, fragment-based screening, DNA-encoded library screening, and high-throughput mass spectrometry.Driven by a passion for overcoming technical and scientific challenges, Dr. Bermingham is dedicated to propelling drug discovery forward and contributing to advancements that will positively impact the field.
Talks About #HighThroughputScreening #DrugDiscovery.EnzymeKinetics
Preferred Locations #NorthAmerica